Sex moderates circadian chemotherapy effects on survival of patients with metastatic colorectal cancer: a meta-analysis von Giacchetti, S., Dugué, P.A., Innominato, P.F., Bjarnason, G.A., Focan, C., Garufi, C., Tumolo, S., Coudert, B., Iacobelli, S., Smaaland, R., Tampellini, M., Adam, R., Moreau, T., Lévi, F.

Volltext

Conversion to resection of liver metastases from colorectal cancer with hepatic artery infusion of combined chemotherapy and systemic cetuximab in multicenter trial OPTILIV von Lévi, F.A., Boige, V., Hebbar, M., Smith, D., Lepère, C., Focan, C., Karaboué, A., Guimbaud, R., Carvalho, C., Tumolo, S., Innominato, P., Ajavon, Y., Truant, S., Castaing, D., De Baere, T., Kunstlinger, F., Bouchahda, M., Afshar, M., Rougier, P., Adam, R., Ducreux, M.

Volltext

Circadian and chemotherapy-related changes in urinary modified nucleosides excretion in patients with metastatic colorectal cancer von Dulong, S., Huang, Q., Innominato, P. F., Karaboue, A., Bouchahda, M., Pruvost, A., Théodoro, F., Agrofoglio, L. A., Adam, R., Finkenstädt, B., Lévi, F.

Volltext

A retrospective review of neutrophil-lymphocyte ratio as a predictive prognostic marker in upper gastrointestinal cancers in three UK hospitals over a nine year period von Wreglesworth, N., Roberts, C., Innominato, P.

Volltext

Effect of immunotherapy-infusion time of day on survival of patients with advanced cancers: a study-level meta-analysis von Landré, T., Karaboué, A., Buchwald, Z.S., Innominato, P.F., Qian, D.C., Assié, J.B., Chouaïd, C., Lévi, F., Duchemann, B.

Volltext

Effects of Light and Food Schedules on Liver and Tumor Molecular Clocks in Mice von Filipski, Elisabeth, Innominato, Pasquale F., Wu, MingWei, Li, Xiao-Mei, Iacobelli, Stefano, Xian, Li-Jian, Lévi, Francis

Volltext

Cross-talks between circadian timing system and cell division cycle determine cancer biology and therapeutics von Lévi, F, Filipski, E, Iurisci, I, Li, X M, Innominato, P

Volltext

ESMO 2014: new trends in precision medicine von Morere, J. F., Innominato, P.

Volltext

Circadian Timing in Cancer Treatments von LEVI, Francis, OKYAR, Alper, DULONG, Sandrine, INNOMINATO, Pasquale F, CLAIRAMBAULT, Jean

Volltext

1038 OBJECTIVE CORRELATES OF SLEEP COMPLAINT IN CANCER PATIENTS ON CHEMOTHERAPY TELE-MONITORED AT HOME: NIGHT-BY-NIGHT ANALYSIS von Komarzynski, S, Lévi, F, Ballesta, A, Bouchahda, M, Haydar, M, Ulusakarya, A, Morère, J, Innominato, PF

Volltext

P-102A retrospective review of neutrophil-lymphocyte ratio as a predictive prognostic marker in upper gastrointestinal cancers in three UK hospitals over a nine year period von Wreglesworth, N, Roberts, C, Innominato, P

Volltext

Resectability after neoadjuvant FOLFIRINOX in locally advanced pancreatic cancer: A single-center experience von Pittau, G, Laurenzi, A, Innominato, P, Gelli, M, Ciacio, O, Allard, M.A, Cherqui, D, Castaing, D, Lewine, M, Adam, R, Sa Cunha, A

Volltext

The mechanism involved in the regulation of phospholipase C gamma 1 activity in cell migration von Piccolo, E, Innominato, P F, Mariggio, MA, Maffucci, T, Iacobelli, S, Falasca, M

Volltext

Colorectal liver metastases are more often super wild type. Toward treatment based on metastatic site genotyping? von Allard, M. A., Saffroy, R., de la Maisonneuve, P. Bouvet, Ricca, L., Bosselut, N., Hamelin, J., Lecorche, E., Bejarano, M. A., Innominato, P., Sebagh, M., Adam, R., Morère, J. F., Lemoine, A.

Volltext

Feasibility of cetuximab given with a simplified schedule every 2 weeks in advanced colorectal cancer: a multicenter, retrospective analysis von Bouchahda, M., Macarulla, T., LIedo, G., Lévi, F., Elez, M. E., Paule, B., Karaboué, A., Artru, P., Tabernero, J., Machover, D., Innominato, P., Goldschmidt, E., Bonnet, D., Ducreux, M., Castagne, V., Guimbaud, R.

Volltext

Detection of melatonin-onset in real settings via wearable sensors and artificial intelligence. A pilot study von Castaldo, R., Chappell, M.J., Byrne, H., Innominato, P.F., Hughes, S., Pescapè, A., Pecchia, L.

Volltext

103P Chemotherapy-induced neutropaenia as a marker for overall survival (OS) in non-small cell lung cancer (NSCLC) patients undergoing gemcitabine/carboplatin (GemCarbo) chemothera... von Clark, Y.F., Vangara, J., Wreglesworth, N., Innominato, P., Mullard, A., Bale, C., Ghosal, N., Garcia-Alonso, A., Fuller, C.

Volltext

A retrospective comparison of frontline platinum in non-squamous non-small-cell lung cancer in North Wales over 9 years von Wreglesworth, N., Chauhan, M., Fuller, C., Mullard, A., Bale, C., Roberts, C., Innominato, P.

Volltext

Sex-related differences in circadian-dependent tolerance of Irinotecan (I) added to chronomodulated (chrono) 5-Fluorouracil (F), Leucovorin (L) and Oxaliplatin (O): Final results f... von Levi, F., Garufi, C., Karaboué, A., Focan, C., Chollet, P., Li, X-M., INNOMINATO, P.

Volltext

Efficacy and tolerability of chronomodulated FOLFIRINOX (chronoIFLO) as 1st or 2nd line treatment in patients (pts) with metastatic colorectal cancer (MCC): Final results from an i... von Garufi, C., Levi, F., Karaboué, A., Torsello, A., Focan, C., Chollet, P., INNOMINATO, P.

Volltext